Hasil Pencarian - H. Tilly

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Comment to: The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92:1335-1342

    Comment to: The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92:1335-1342 oleh P Bertrand, C Maingonnat, P Ruminy, H Tilly, C Bastard

    Diterbitkan 2008-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    P1217: INTRATHECAL METHOTREXATE PROPHYLAXIS AND CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH INTENSIFIED R-ACVBP STRATEGY

    P1217: INTRATHECAL METHOTREXATE PROPHYLAXIS AND CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH INTENSIFIED R-ACVBP STRATEGY oleh L. Renaud, P. Stéphan, S. durand, G. Escure, M. Franck, V. camus, H. tilly, O. casasnovas, S. Chevret, C. Thieblemont

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma

    Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma oleh S. Draye-Carbonnier, V. Camus, S. Becker, D. Tonnelet, E. Lévêque, A. Zduniak, F. Jardin, H. Tilly, P. Vera, P. Decazes

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Transformation of an Unclassified Myeloproliferative Neoplasm with a Rare BCR-JAK2 Fusion Transcript Resulting from the Translocation (9;22)(p24;q11)

    Transformation of an Unclassified Myeloproliferative Neoplasm with a Rare BCR-JAK2 Fusion Transcript Resulting from the Translocation (9;22)(p24;q11) oleh A. N. Chamseddine, P. Etancelin, D. Penther, F. Parmentier, C. Kuadjovi, V. Camus, N. Contentin, P. Lenain, C. Bastard, H. Tilly, F. Jardin

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    P1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

    P1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE L... oleh A. McMillan, C. Haioun, J.-M. Sancho, A. Viardot, A. Rodriguez Izquierdo, E. M. Donato Martin, A. M. García-Sancho, J. Sandoval-Sus, H. Tilly, E. Vandenberghe, J. Hirata, P. Choudhry, Y. M. Chang, L. Musick, M. Matasar

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    P1192: ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL

    P1192: ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL oleh Y. Song, J. Jin, H. Tilly, H. Zhang, J. Cao, J. Feng, L. Zhang, S. Rai, H. Goto, Y. Terui, W. S. Kim, H.-J. Shin, J.-P. Gau, C.-H. Tsai, J. P. Sharman, L. Bu, J. Hirata, C. Lee, K. Izutsu, J. Zhu

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY

    P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY oleh M. Trněný, L. Fogliatto, F. Gardner, I. Flinn, J.-F. Larouche, C. Haioun, M. Canales, H. Goto, R. Hajek, G. Salles, J. Qiu, A. Campinha-Bacote, M. Yan, R. Kothari, G. Man, D. Sahin, J. Hirata, C. Lee, H. Tilly, C. Flowers

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2 RANDOMIZED ROSEWOOD TRIAL

    S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2... oleh P. L. Zinzani, J. Mayer, R. Auer, F. Bijou, A. C. de Oliveira, C. R. Flowers, M. Merli, K. Bouabdallah, P. S. Ganly, Y. Song, H. Zhang, R. Johnson, A. M García-Sancho, M. Provencio, M. Trněný, S. Yuen, H. Tilly, E. Kingsley, G. Tuyman, S. E. Assouline, E. Ivanova, P. Kim, J. Huang, R. Delarue, J. Trotman

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY.

    P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE II... oleh G. Cartron, MD, PhD, E. Bachy, MD, PhD, H. Tilly, MD, N. Daguindau, MD, G.-M. Pica, MD, F. Bijou, MD, C. Mounier, MD, A. M. Clavert, MD, G. L. Damaj, MD, PhD, B. Slama, MD, O. Casasnovas, MD, R. Houot, MD, PhD, K. Bouabdallah, MD, D. Sibon, MD, PhD, O. Fitoussi, MD, N. Morineau, MD, C. Herbaux, MD, PhD, T. Gastinne, MD, L.-M. Fornecker, MD, C. Haioun, MD, PhD, V. Launay, MD, C. Araujo, MD, O. Benbrahim, MD, L. Sanhes, MD, R. Gressin, MD, H. Gonzalez, MD, F. Morschhauser, MD, PhD, L. Xerri, MD, PhD, K. Tarte, PhD, D. Pranger, MD

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: